(Q42478334)

1 November 2017

title

Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica (English)

1 reference

1 November 2017

1 reference

Fasciola hepatica

1 reference

C Devine

1

1 reference

1 November 2017

G P Brennan

2

1 reference

1 November 2017

C E Lanusse

3

1 reference

1 November 2017

L I Alvarez

4

1 reference

1 November 2017

A Trudgett

5

1 reference

1 November 2017

E Hoey

6

1 reference

1 November 2017

I Fairweather

7

1 reference

1 November 2017

publication date

15 October 2010

1 reference

1 November 2017

1 reference

1 November 2017

volume

138

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

224-236

1 reference

Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen').

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Plasma achiral and chiral pharmacokinetic behaviour of intravenous oxfendazole co-administered with piperonyl butoxide in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Benzimidazole drugs and modulation of biotransformation enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fasciola hepatica: Basal infolds and associated vacuoles of the tegument

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fenbendazole pharmacokinetics, metabolism, and potentiation in horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fasciola hepatica: tegumental changes induced in vitro by the deacetylated (amine) metabolite of diamphenethide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

Fasciola hepatica: tegumental alterations as a consequence of lectin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

7 January 2021

Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

7 January 2021

Interaction between Fenbendazole and Piperonyl Butoxide: Pharmacokinetic and Pharmacodynamic Implications

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

7 January 2021

The metabolism of benzimidazole anthelmintics

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

7 January 2021

Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

7 January 2021

The interaction between the deacetylated (amine) metabolite of diamphenethide (DAMD) and cytochemically demonstrable Na+/K+-ATPase activity in the tegument of Fasciola hepatica

1 reference

https://api.crossref.org/works/10.1017%2FS0031182010001125

7 January 2021

10.1017/S0031182010001125

Identifiers

DOI

1 reference

1 November 2017

1 reference